Amorphous Dispersion Speciation: Impact of Polymer Chemistry and Molecular Weight
Amorphous Dispersion Speciation: Impact of Polymer Chemistry and Molecular Weight
Wesley K. Tatum, Ph.D.
Principal Engineer
Abstract:
Spray-dried dispersions (SDDs) are a key technology for enhancing bioavailability of poorly water-soluble compounds. SDD formulations enable increased intestinal absorption through two primary mechanisms: (1) increasing concentration of solvated drug leading to a higher driving force for passive diffusion through the intestinal epithelium, and (2) formation of colloidal species leading to increased rates of diffusion through the unstirred water layer and a rapid resupply of solvated drug at the surface of epithelial cells. While the former is achieved through the amorphous form, the latter is dependent on the formation and nature of colloidal species that are characteristic of SDD formulations.
Our previous work has shown distinct differences in polymer speciation in a given biorelevant media as a result of concentration and polymer chemistry. The goal of the current study is to evaluate how molecular weight and flexibility influences the partitioning of drug molecules into the polymer colloids.
Learning Objectives:
Understand the importance of speciation in amorphous solid dispersions
Understand the differences between polymer colloids formed from different polymers used in amorphous dispersions
Understand how molecular properties can influence the interactions between drugs and polymers
ABOUT THE AUTHOR:
Wesley Tatum is a Principal Engineer in the Process and Product Development department at Serán. He leads a team of scientists and engineers in characterizing new API and identifying shortcomings for bioavailability. He and his team then screen and select drug product intermediates that address those shortcomings and screen and scale up drug product formulations. During his time at Serán, his work and research has focused on understanding how polymers, excipients, and physiological factors influence speciation, bioavailability, and absorption of drug substances and amorphous solid dispersions.
Wesley holds undergraduate degrees in Physics and Physical Chemistry from Whitworth University and a Ph.D. in Materials Science and Engineering from the University of Washington.
About Serán
Serán BioScience, LLC, is a science-driven Drug Development Partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, visit www.Seranbio.com or email us at hello@seranbio.com.
Contact
Serán BioScience, LLC
63047 Layton Ave, Bend, OR 97701 USA
www.seranbio.com
.avif)
